Inventor

GASTER LARAMIE MARY

GB35 patents

⚠️ This page may combine multiple inventors who share the name “GASTER LARAMIE MARY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

GASTER LARAMIE MARY

SMITHKLINE BEECHAM PLC

Indole derivatives as 5-HT receptor antagonist

Amide and urea derivatives as 5HT1D receptor antagonists

Heterocyclic compounds possessing 5HT2C receptor antagonist activity

Condensed indole derivatives as 5HT4 -receptor antagonists

Heterocyclic biphenylylamides useful as 5HT1D antagonists

5-HT4 receptor antagonist

Piperidine derivatives as 5-HT4 receptor antagonists

N-alkylpiperidinyl-4-methyl carboxylic esters/amides of condensed ring systems as 5-HT4 receptor antagonists

5-HT4 antagonists

Medicaments 1,2,3,4-tetrahydrocarbazoles and 5-HT1 agonist use thereof

Condensed indole derivatives as 5HT4 -receptor antagonists

Indole, indoline and quinoline derivatives with 5HT1D (anti-depressive) activity

Biphenylamide compounds as 5HT1D Antagonists

Bicyclic aryl or a bicyclic heterocyclic ring containing compounds having a combined 5HT1A, 5HT1B and 5HT1D receptor antagonistic activity

Tricyclic heterocyclic compounds as 5-HT4 receptor antagonists

Indole derivatives as 5-HT receptor antagonist

Biphenylamide derivatives as 5HT1D antagonists

Benzopyran, benzothiopyran and benzofuran derivatives as 5-HT4 antagonists

Heterocyclic-esters or -amides used as 5-HT4 receptor antagonists

Indole and indoline derivatives as 5HT1D receptor antagonists

Bicyclic compounds as ligands for 5-HT1 receptors

Amide derivatives having 5HT1D-antagonist activity

Azaspiro derivatives with 5HT1B activity

Biphenyl(thio)amide and bipennylethan(thi) one derivatives, their preparation and their use as 5-HT1D receptor antagonists

Dihydrobenzofuranyl-biphenyl carboxamides having 5HT1D antagonistic activity

Indole derivatives as 5-HT receptor antagonist

Tetracyclic spiro compounds as 5HT1B receptor antagonists

Tetracyclic spiro compounds, process for their preparation and their use as 5HT1D receptor antagonists

Tricyclic spiro compounds process for their preparation and their use of 5HT1D receptor antagonists

5-HT4 receptor antagonists

5-HT4 receptor antagonists useful in the treatment of gastroinstestinal, cardiovascular and CNS disorders

Tricyclic spiro compounds as 5HT1D receptor antagonists

Heteroaryl compounds used as pharmaceuticals

Spiroazabicyclic compounds, processes for their preparation, and their pharmaceutical use

SMITHKLINE BEECHAM CORP

Triarylimidazole derivatives as cytokine inhibitors